Alemtuzumab and nephritis autoimmune Patient Reports February 13, 2012

Alemtuzumab Side Effects Report #5863920-7
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5866798-0
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5870151-3
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 18, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5871967-X
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 18, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.


Alemtuzumab Side Effects Report #5977134-3
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 27, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5982292-0
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 27, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute, renal transplant. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #6096839-X
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Feb 14, 2009. Female patient, 40 years of age, was diagnosed with multiple sclerosis  and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5863917-7
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Male patient, 43 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.

Alemtuzumab Side Effects Report #5866799-2
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2008. Male patient, 43 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: dialysis , glomerulonephritis rapidly progressive, nephritis autoimmune, renal failure acute, renal transplant. Alemtuzumab dosage: unknown. Patient recovered.


Alemtuzumab Side Effects Report #5874123-4
Alemtuzumab side effect was reported by a Health Professional from UNITED KINGDOM on Aug 18, 2008. Male patient, 43 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: nephritis autoimmune, renal failure acute. Alemtuzumab dosage: unknown. Patient recovered.